Glipalamide

This classification denotes an anti-diabetic agent with the molecular formula C12H15N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) W7J490CUHM, chemically known as 4,5-dihydro-5-methyl-n-((4-methylphenyl)sulfonyl)-1h-pyrazole-1-carboxamide but more generally known as glipalamide, which bears US NIH Compound Identifier 65802. European Medicines Agency schedules Glipalamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07926MIG. The term GLIPALAMIDE is an International Non-Proprietary Name. GLIPALAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule glipalamide under HS 29350090 and SITC 51580. As of Q4 2014, GLIPALAMIDE remains US FDA's Preferred Term for this commodity. Glipalamide bears US NLM identifiers UMLS ID C0243356 and NCI Concept Code C72797. SMILES: CC1CC=NN1C(=O)NS(=O)(=O)C2=CC=C(C=C2)C.